• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

tau 病的分子发病机制。

Molecular Pathogenesis of the Tauopathies.

机构信息

Clem Jones Centre for Ageing Dementia Research, Queensland Brain Institute, The University of Queensland, St. Lucia Campus, Brisbane, Queensland 4072, Australia; email:

Brain and Mind Centre and Central Clinical School, Sydney Medical School, University of Sydney, New South Wales 2006, Australia.

出版信息

Annu Rev Pathol. 2019 Jan 24;14:239-261. doi: 10.1146/annurev-pathmechdis-012418-012936. Epub 2018 Oct 24.

DOI:10.1146/annurev-pathmechdis-012418-012936
PMID:30355155
Abstract

The tauopathies constitute a group of diseases that have Tau inclusions in neurons or glia as their common denominator. In this review, we describe the biochemical and histological differences in Tau pathology that are characteristic of the spectrum of frontotemporal lobar degeneration as primary tauopathies and of Alzheimer's disease as a secondary tauopathy, as well as the commonalities and differences between the familial and sporadic forms. Furthermore, we discuss selected advances in transgenic animal models in delineating the different pathomechanisms of Tau.

摘要

神经tau 病是以神经元或神经胶质细胞内存在 Tau 包涵体作为共同特征的一组疾病。在这篇综述中,我们描述了 Tau 病理学在神经退行性疾病中的生物化学和组织学差异,这些差异是额颞叶痴呆作为原发性 Tau 病和阿尔茨海默病作为继发性 Tau 病的特征,以及家族性和散发性形式之间的异同。此外,我们还讨论了转基因动物模型在阐明 Tau 不同病理机制方面的一些进展。

相似文献

1
Molecular Pathogenesis of the Tauopathies.tau 病的分子发病机制。
Annu Rev Pathol. 2019 Jan 24;14:239-261. doi: 10.1146/annurev-pathmechdis-012418-012936. Epub 2018 Oct 24.
2
Detection of Alzheimer's disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau).采用与 tau 构象选择性结合的抗 tau 单克隆抗体检测共病额颞叶变性-tau(FTLD-tau)中的阿尔茨海默病(AD)特异性 tau 病理学。
Acta Neuropathol Commun. 2019 Mar 4;7(1):34. doi: 10.1186/s40478-019-0687-5.
3
Tauopathies: Deciphering Disease Mechanisms to Develop Effective Therapies.tau 病:破解疾病机制以开发有效疗法。
Int J Mol Sci. 2020 Nov 25;21(23):8948. doi: 10.3390/ijms21238948.
4
Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies.废弃术语 FTDP-17,因为 MAPT 突变是散发性额颞叶tau 病的遗传形式。
Brain. 2018 Feb 1;141(2):521-534. doi: 10.1093/brain/awx328.
5
Tau physiology and pathomechanisms in frontotemporal lobar degeneration.额颞叶变性中tau蛋白的生理功能及发病机制
J Neurochem. 2016 Aug;138 Suppl 1(Suppl Suppl 1):71-94. doi: 10.1111/jnc.13600. Epub 2016 Jun 15.
6
Ante mortem cerebrospinal fluid tau levels correlate with postmortem tau pathology in frontotemporal lobar degeneration.生前脑脊液tau水平与额颞叶变性中的死后tau病理学相关。
Ann Neurol. 2017 Aug;82(2):247-258. doi: 10.1002/ana.24996. Epub 2017 Aug 19.
7
Mixed TDP-43 proteinopathy and tauopathy in frontotemporal lobar degeneration: nine case series.伴有 TDP-43 蛋白和 tau 蛋白病理改变的额颞叶变性:9 个病例系列。
J Neurol. 2018 Dec;265(12):2960-2971. doi: 10.1007/s00415-018-9086-2. Epub 2018 Oct 15.
8
Neuropathology of frontotemporal lobar degeneration-tau (FTLD-tau).额颞叶变性-tau 型神经病理学(FTLD-tau)。
J Mol Neurosci. 2011 Nov;45(3):384-9. doi: 10.1007/s12031-011-9589-0. Epub 2011 Jul 1.
9
Cellular and pathological heterogeneity of primary tauopathies.原发性 tau 病的细胞和病理学异质性。
Mol Neurodegener. 2021 Aug 23;16(1):57. doi: 10.1186/s13024-021-00476-x.
10
Evaluating the Patterns of Aging-Related Tau Astrogliopathy Unravels Novel Insights Into Brain Aging and Neurodegenerative Diseases.评估衰老相关的tau蛋白星形胶质细胞病模式为脑衰老和神经退行性疾病揭示了新的见解。
J Neuropathol Exp Neurol. 2017 Apr 1;76(4):270-288. doi: 10.1093/jnen/nlx007.

引用本文的文献

1
Tauopathies: Calmodulin Regulates Tau Hyperphosphorylation and Its Transformation into Disease-Specific Aggregates.tau蛋白病:钙调蛋白调节tau蛋白的过度磷酸化及其向疾病特异性聚集体的转变。
Biomolecules. 2025 Aug 6;15(8):1133. doi: 10.3390/biom15081133.
2
Twenty years of therapeutic development in tauopathy mouse models: a scoping review.在tau蛋白病小鼠模型中二十年的治疗进展:一项范围综述。
Alzheimers Dement. 2025 Aug;21(8):e70578. doi: 10.1002/alz.70578.
3
Upregulating ANKHD1 in PS19 Mice Reduces Tau Phosphorylation and Mitigates Tau Toxicity-Induced Cognitive Deficits.
上调PS19小鼠中的ANKHD1可减少tau蛋白磷酸化并减轻tau毒性诱导的认知缺陷。
Int J Mol Sci. 2025 Aug 4;26(15):7524. doi: 10.3390/ijms26157524.
4
Rational Modulation of Liquid-Liquid Phase Separation Offers Novel Ways to Combat Tauopathies.液-液相分离的合理调控为对抗tau蛋白病提供了新方法。
Int J Mol Sci. 2025 Jul 12;26(14):6709. doi: 10.3390/ijms26146709.
5
Decoding tau acetylation in Alzheimer's disease and tauopathies: from site-specific mechanisms to therapeutic horizons.解析阿尔茨海默病和tau蛋白病中的tau蛋白乙酰化:从位点特异性机制到治疗前景
BMB Rep. 2025 Aug;58(8):325-339.
6
TMEM59 deficiency activates chaperone-mediated autophagy and ameliorates disease-like pathologies in tauopathy model mice.跨膜蛋白59(TMEM59)缺乏激活伴侣介导的自噬并改善tau蛋白病模型小鼠的疾病样病理变化。
Alzheimers Dement. 2025 Jun;21(6):e70369. doi: 10.1002/alz.70369.
7
Polyamination with spermidine enhances pathogenic tau conformations while reducing filamentous aggregate formation in vitro.用亚精胺进行多胺化反应可增强致病性tau构象,同时在体外减少丝状聚集体的形成。
Biochem J. 2025 Jun 17;482(12):877-99. doi: 10.1042/BCJ20253079.
8
Alzheimer's Disease and Frontotemporal Dementia: A Review of Pathophysiology and Therapeutic Approaches.阿尔茨海默病与额颞叶痴呆:病理生理学与治疗方法综述
J Neurosci Res. 2025 May;103(5):e70046. doi: 10.1002/jnr.70046.
9
Autophagy Dysfunction and Neurodegeneration: Where Does It Go Wrong?自噬功能障碍与神经退行性变:问题出在哪里?
J Mol Biol. 2025 Sep 15;437(18):169219. doi: 10.1016/j.jmb.2025.169219. Epub 2025 May 16.
10
Decoupling Phase Separation and Fibrillization Preserves Activity of Biomolecular Condensates.解耦相分离和纤维化可保留生物分子凝聚物的活性。
Res Sq. 2025 Apr 29:rs.3.rs-6405673. doi: 10.21203/rs.3.rs-6405673/v1.